Research

April 17, 2014

VICC’s Arteaga assumes presidency of AACR

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology and Donna S. Hall Professor of Breast Cancer Research at Vanderbilt-Ingram Cancer Center (VICC), assumed the presidency of the American Association for Cancer Research (AACR) for 2014-2015 during the group’s annual meeting last week in San Diego.

By VUMC News and Communications
April 17, 2014

Redesign of nursing workflow seeing success

In 2008, Vanderbilt nurses participated in a nationwide survey to determine how they spent their time, and it revealed that only 16 percent was spent on direct patient care, while 28 percent was spent on documentation.

By VUMC News and Communications
April 17, 2014

Nutrient-absorbing surface’s assembly revealed: study

Vanderbilt University researchers have discovered how intestinal cells build the “brush border” — a specialized surface structure that is critical for absorbing nutrients and defending against pathogens.

By Leigh MacMillan
April 16, 2014

Channel drug restores glucose balance

A new compound that activates potassium channels could be used to treat disorders of glucose homeostasis.

By Bill Snyder
April 15, 2014

Anthrax bacteria’s signaling systems

Vanderbilt researchers have identified a new signaling system that anthrax bacteria uses to infect its host.

By Leigh MacMillan
April 11, 2014

Myelin junctions key to conduction

A protein in the myelin coating on nerves helps form a “seal” that enables effective nerve conduction; loss of the protein causes inherited neuropathies.

By Leigh MacMillan
April 10, 2014

Study tracks new lung cancer drug target

Researchers at Vanderbilt University have identified a potential new drug target in subtypes of lung cancer that are difficult to treat.
By Bill Snyder
April 10, 2014

Matrix remodeling and insulin resistance

The extracellular matrix that surrounds cells plays a role in the development of insulin resistance.
By Will Fry
April 3, 2014

DBS for Parkinson’s trial moves to next level

A long-term Vanderbilt University Medical Center study of deep brain stimulation (DBS) in early-stage Parkinson’s disease has received approval from the Food and Drug Administration (FDA) to continue in a pivotal, phase III, large-scale safety and efficacy trial.
By VUMC News and Communications
April 3, 2014

Protein’s role in spread of colon cancer studied

One of the most formidable weapons in a cancer’s arsenal is the ability to spread to other organs.
By VUMC News and Communications
April 3, 2014

Agarwal’s macular diseases research lands high honor

Walk into ophthalmologist Anita Agarwal’s office at the Vanderbilt Eye Institute and there is something remarkably different about the décor.
By Jessica Pasley
April 3, 2014

Grant aids search for Restless Legs Syndrome treatment

Vanderbilt University Medical Center has been selected as one of three sites to share a three-year, $1.3 million grant from the National Institutes of Health (NIH) to explore the potential therapeutic properties of manganese, a chemical element and biologically essential trace mineral, in treating Restless Legs Syndrome (RLS).
By VUMC News and Communications
April 2, 2014

VU study tracks urinary incontinence therapy

More than 15 million women in the United States are impacted by stress urinary incontinence (SUI) at a cost of nearly $20 billion a year to treat.
By Jessica Pasley